Division of International Strategy International Collaborative Research Program: Strategic International Collaborative Research Program (SICORP)
Outline
| Key Fields | Innovation and Clinical Research Center Project |
|---|---|
| R&D phase | Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study |
| Contact |
|
The aim of this program is to contribute solutions to challenges facing world today and to bolster Japan’s scientific and technological capabilities through collaboration with a broad range of countries．
This program provides support for international joint research projects on the basis of equal partnership in countries，regions，and fields of cooperation that have been designated as particularly important by the Ministry of Education，Culture，Sports，Science and Technology（MEXT）on the basis of intergovernmental agreements，in collaboration with funding agencies in the countries concerned．
Implementing Body
SICORP (Singapore)
- Research Area – "Biological and Molecular Determinants of Human Ageing"
- The aims are to: 1) strengthen research collaborations between Japan and Singapore within the field of ”Biological and Molecular Determinants of Human Ageing”; and 2) achieve world-class scientific results through the development and use of new and innovative technologies which can address the challenges facing the international community in the area of health research in both countries.
- Funding Agency of Singapore Side
- Agency for Science, Technology and Research (A*STAR)
- Duration: FY2017 - FY2021
| Project Title | Biological signatures of cardiovascular, musculoskeletal and cognitive ageing in the very old | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. ARAI Yasumichi | Dr. Woon-Puay Koh |
| Affiliation | Keio University School of Medicine | Duke-NUS Medical School |
| Project Title | Effect of aging of the innate immune system on intracellular system network | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. FUJIU Katsuhito | Dr. Xiaomeng Wang |
| Affiliation | The University of Tokyo | Singapore Eye Research Institute (SERI) |
| Project Title | Targeting age-associated white matter lesions | |
|---|---|---|
| Country | Japan | Singapore |
| PI |
Dr. IHARA Masafumi |
Dr. Peter Tsun-Hon Wong |
| Affiliation | National Cerebral and Cardiovascular Center | National University of Singapore |
Research Area – "Cell Therapy - a focus on quality, efficacy and safety"- The aims are to: 1) strengthen research collaborations between Japan and Singapore within the field of ”Cell Therapy - a focus on quality, efficacy and safety” ; and 2) achieve world-class scientific results through the development and use of new and innovative technologies which can address the challenges facing the international community in the area of health research in both countries.
- Funding Agency of Singapore Side
- Agency for Science, Technology and Research (A*STAR)
- Duration: FY2019 - FY2022
| Project Title | Developing a safe and potentially efficacious piggyBac-based CAR-T cell strategy for virus-related cancers | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. SAITO Shoji | Dr. Timothy Wai Ho Shuen |
| Affiliation | Department of Pediatric, Shinshu University | Division of Medical Oncology, National Cancer Centre Singapore |
| Project Title | Large-scale Preparation of Hair Follicle Germs using Hydrogel Printing | |
|---|---|---|
| Country | Japan | Singapore |
| PI | Dr. KAGEYAMA Tatsuto | Dr. Michinao Hashimoto |
| Affiliation | Kanagawa Institute of Industrial Science and Technology (KISTEC) | Singapore University of Technology and Design |
| Project Title | Human stem cell-derived pancreatic beta cells for the treatment of diabetes | |
|---|---|---|
| Country | Japan | Singapore |
| PI |
Dr. SHIRAKAWA Jun |
Dr. Adrian Kee Keong Teo |
| Affiliation | Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation, Gunma University | A*STAR/NUS Medicine, the Institute of Molecular and Cell Biology (IMCB) |
SICORP (Spain)
- Research Area – "Nanomedicine"
- The aims are to:
1) Strengthen research collaborations between Japan and Spain within the field of Nanomedicine;
2) Achieve world-class scientific results through the development and use of new and innovative
technologies which can address the challenges facing the international community in the area of
health research in both countries. - Funding Agency of Spain Side
- State Research Agency of Spain （AEI）
- Duration: FY2018 - FY2021
| Project Title | Development of phototherapeutic strategies for amyloid-related diseases enabled by a nanoscale view of amyloid photodamage (AMYLIGHT) | |
|---|---|---|
| Country | Japan | Spain |
| PI | Dr. SOHMA Youhei | Dr. Cristina Flors |
| Affiliation | Wakayama Medical University | IMDEA Nanociencia |
| Project Title | Drug delivery targeting Brain CPT1: a novel nanomedicine-based approach to fight obesity and cancer (COnCorD) | |
|---|---|---|
| Country | Japan | Spain |
| PI | Dr. Sabina Quader | Dr. Rosalía Rodríguez-Rodríguez |
| Affiliation | Innovation Centre of Nanomedicine (iCONM) | Universidad Internacional de Cataluña |
| Project Title | Nano-scaffolding for neuronal migration and regeneration (Nano-ReBrain) | |
|---|---|---|
| Country | Japan | Spain |
| PI | Dr. KANEKO Naoko | Dr. Vicente Herranz-Pérez |
| Affiliation | Nagoya City University | Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED) |
SICORP (UK)
- Research Area – "Infectious Diseases"
- The overarching aim of the UK-Japan collaborative initiative in infectious diseases is to provide bi-lateral support to biomedical and health researchers in the UK and Japan that will allow them to forge lasting collaborations. This initative aims to strengthen existing links or foster new links that add value to research taking place in both countries. This is expected to be achieved by facilitating exchange and catalysing innovative synergy amongst collaborators and is particularly aimed at those who are in the early stages of their careers.
- Funding Agency of the UK Side
- The UK Medical Research Council（MRC）
- Duration: FY2019 - FY2022
| Project Title | Elucidation of cell-autonomous immunity and host defense against Toxoplasma gondii by interferon-inducible GTPases | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. YAMAMOTO Masahiro | Dr. Eva-Maria Frickel |
| Affiliation | Research Institute for Microbial Diseases, Osaka University | The University of Birmingham |
| Project Title | Interferon stimulated defences that target Hepatitis B Virus (HBV) and Hepatitis D Virus (HDV) | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. WATASHI Koichi | Dr. Sam Wilson |
| Affiliation | National Institute of Infectious Diseases | MRC University of Glasgow Centre for Virus Research (CVR) |
| Project Title | Dynamic Imaging in Viral Encephalitis Defines Unique Roles for Chemoattractants | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. MIYABE Yoshishige | Dr. Benedict Michael |
| Affiliation | Nippon Medical School | University of Liverpool |
| Project Title | The HDAC6/USP7 axis in enveloped RNA virus infection | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. MIYAKE Yasuyuki | Dr. Yohei Yamauchi |
| Affiliation | Nagoya University Graduate School of Medicine | University of Bristol School of Cellular and Molecular Medicine |
| Project Title | Systematic analysis of persistence mechanisms by high-throughput bar-seq and single cell analyses | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. MUTO-FUJITA Ai | Dr. Suzie Hingley-Wilson |
| Affiliation | RIKEN | University of Surrey |
| Project Title | A cross-sectional approach to identification & interrogation of adaptive & functional mutations affecting CCHFV replication & pathogenicity in humans | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. MORITA Kouichi | Dr. David Allen |
| Affiliation | Institute of Tropical Medicine, Nagasaki University | London School of Hygiene and Tropical Medicine (LSHTM) |
| Project Title | Study of the T cell Response During Cryptococcal Meningitis Using New Tools | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. KAWAKAMI Kazuyoshi | Dr. Rebecca Drummond |
| Affiliation | Tohoku University Graduate School of Medicine | University of Birmingham |
| Project Title | The human T-cell leukaemia virus HTLV-1: transcriptional heterogeneity at the single-cell level | |
|---|---|---|
| Country | Japan | U.K. |
| PI | Dr. SATO Yorifumi | Dr. Charles Bangham |
| Affiliation | Kumamoto University | Imperial College |
SICORP (Germany)
- Research Area – "Neuroscience - Computational Connectomics"
- The aim of the collaborative project is to provide bi-lateral support to biomedical and health researchers in Japan and Germany that will allow them to forge lasting collaborations in the field of neuroscience-computational connectomics.
- Funding Agency of German Side
- Deutsche Forschungsgemeinschaft e.V (DFG)
- Duration: FY2020 - FY2023
| Project Title | Computational and Physiological Approaches to the Primate Anxiety Connectome | |
|---|---|---|
| Country | Japan | Germany |
| PI | Dr. AMEMORI Ken-ichi | Prof. Dr. Peter Dayan |
| Affiliation | Kyoto University | Max Planck Institute for Biological Cybernetics / University of Tübingen |
| Project Title | The role of dynamic neural functional coupling in spontaneous thought | |
|---|---|---|
| Country | Japan | Germany |
| PI | Dr. Mingbo Cai | Dr. Nicolas Schuck |
| Affiliation | The University of Tokyo | Max Planck Institute for Human Development |
SICORP (Canada)
- Research Area – "Advancing Epigenetic Technologies"
- The aim is to support Japan- and Canada-based early career researchers develop fruitful international collaborations in the field of epigenetic mechanisms and technologies.
- Funding Agency of Canadian Side
- Canadian Institutes of Health Research (CIHR)
- Duration: FY2020 - FY2023
| Project Title | Artificial Intelligence based adaptive and interpretable models for analyzing multi-track epigenomic sequential data | |
|---|---|---|
| Country | Japan | Canada |
| PI | Dr. YAMANAKA Soichiro | Dr. Ahmed Ashraf |
| Affiliation | The University of Tokyo | University of Manitoba |
| Project Title | Single-cell probing of epigenetic memory in immunity | |
|---|---|---|
| Country | Japan | Canada |
| PI | Dr. Jay Shin | Dr. David Langlais |
| Affiliation | RIKEN | McGill University |
| Project Title | Characterization of the integrative epigenetic and epitranscriptomic landscape of acute myeloid leukemias |
|
|---|---|---|
| Country | Japan | Canada |
| PI | Dr. YOSHIMI Akihide | Dr. Ly Vu |
| Affiliation | National Cancer Center Research Institute | Simon Fraser University |
Results Report
Management and Evaluation Framework
PS（Program Supervisor）
SUDA Toshio, M.D., Ph.D., Director and Professor, International Research Center for Medical Sciences, Kumamoto University / Professor, Cancer Science Institute, National University of SingaporePO（Program Officer）
SICORP (Singapore)
Research Area - "Biological and Molecular Determinants of Human Ageing"AKISHITA Masahiro, M.D., Ph.D., Professor, Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo / Vice Director, Institute of Gerontology, The University of Tokyo / Vice Director, The University of Tokyo Hospital
Research Area - "Cell Therapy - a fucus on quality, efficacy and safety"SHIKU Hiroshi, M.D., Ph.D., Professor, Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine
SICORP (Spain)
HANDA Hiroshi, M.D., Ph.D., Professor, Department of Nanoparticle Translational Research, Tokyo Medical University
SICORP (UK)
SATO Hironori, M.D., Ph.D., Chief, Pathogen Genomics Center, The National Institute of Infectious Diseases
SICORP (Germany)
ISA Tadashi, M.D., Ph.D., Professor of Neuroscience, Graduate School of Medicine, Kyoto University
SICORP (Canada)
USHIJIMA Toshikazu, M.D., Ph.D., Chief, Division of Epigenomic, National Cancer Center Research Institute
Brochure
Last updated 2021.4.1